Abnormal platelet response to PAF and ADP in β-thalassaemia

International Journal of Biochemistry

Volumn 20, Issue 6, 1988, Pages 599-604

  Demopoulos, Constantinos A ^a   Andrikopoulos, Nikolaos K ^b   Stathopoulou Sparou, Regina ^c  

^a UNIVERSITY OF ATHENS   (Greece)

^b Hepatology Service   (Greece)

^c P AND A KYRIAKOU CHILDREN S HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; THROMBOCYTE ACTIVATING FACTOR;

BETA THALASSEMIA; CLINICAL ARTICLE; FEMALE; HUMAN CELL; MALE; SPLENECTOMY; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; COMPARATIVE STUDY; HETEROZYGOTE DETECTION; HOMOZYGOTE; HUMAN; IN VITRO; KINETICS; PLATELET ACTIVATING FACTOR; PLATELET AGGREGATION; REFERENCE VALUES; SPLENECTOMY; THALASSEMIA;

EID: 0023898252     PISSN: 0020711X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0020-711X(88)90099-7     Document Type: Article

References (17)

1. High performance liquid Chromatographic analysis of platelet activating factor on a cation-exchange column by direct ultraviolet detection
2. Platelet-activating factor: an ether lipid with biological activity
3. Antihypertasive activity of an alkyl ether analog of phosphatidylcholine
4. Presence of platelet activating factor in blood from humans and experimental animals. Its absence in anephric individuals
5. Platelets activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators)
6. Abnormal platelet functions in β-thalassaemia
7. Preliminary studies of an acid-labile factor (ALF) in human sera that inctivates platelet-activating factor (PAF)
8. Identification of naturally occurring platelet activating factor as acetyl glyceryl ether phosphoryl choline (AGEPC)
9. The effect of acetyl glycerylether phosphorylcholine (AGEPC) on normal human platelets in vitro
10. Function, metabolism and regulation of Platelet Activating Factor and related ether lipids
11. Plasma inhibitors of platelet function in β-thalassaemia
12. Human platelet stimulation by acetyl glyceryl ether phosphorylcholine
13. Absence of platelet activating factor (PAF) mediated platelet aggregation: a new platelet defect
14. Platelet dysfunction in homozygous β-thalassaemia
15. Semisynthese et structure proposee du facteur activant des plaquettes (PAF): PAF-acether, un alkyl ether analogue de la lysophosphatidyl choline
16. Background and present status of research on platelet-activating factor (PAF-acether)
17. Defective platelet activating factor (PAF) in myeloproliferative disorders: deficiency of an aspirinindependent mechanism